ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection

Control of human ascariasis, the most prevalent neglected tropical disease globally affecting 450 million people, mostly relies on mass drug administration of anthelmintics. However, chemotherapy alone is not efficient due to the high re-infection rate for people who live in the endemic area. The de...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazzinelli-Guimarães, Ana Clara, Nogueira, Denise Silva, Amorim, Chiara Cássia Oliveira, Oliveira, Fabrício Marcus Silva, Coqueiro-Dos-Santos, Anderson, Carvalho, Samuel Alexandre Pimenta, Kraemer, Lucas, Barbosa, Fernando Sérgio, Fraga, Vanessa Gomes, Santos, Flaviane Vieira, de Castro, Joseane Camilla, Russo, Remo Castro, Akamatsu, Milena Apetito, Ho, Paulo Lee, Bottazzi, Maria Elena, Hotez, Peter J., Zhan, Bin, Bartholomeu, Daniella Castanheira, Bueno, Lilian Lacerda, Fujiwara, Ricardo Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724438/
https://www.ncbi.nlm.nih.gov/pubmed/34992603
http://dx.doi.org/10.3389/fimmu.2021.788185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724438/
https://www.ncbi.nlm.nih.gov/pubmed/34992603
http://dx.doi.org/10.3389/fimmu.2021.788185

Ejemplares similares